Preventive evidence into practice (PEP) study: implementation of guidelines to prevent primary vascular disease in general practice protocol for a cluster randomised controlled trial by Harris, Mark F et al.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Archived at the Flinders Academic Commons: 
http://dspace.flinders.edu.au/dspace/ 
This is the publisher’s copyright version of this article. 
The original can be found at:  
http://www.implementationscience.com/content/8/1/8 
Harris, M.F., Lloyd, J., Litt, J.C., van Driel, M., Mazza, D., 
Russell, G. et al., 2013.Preventive evidence into practice 
(PEP) study: implementation of guidelines to prevent 
primary vascular disease in general practice protocol for a 
cluster randomised controlled trial. Implementation 
Science, 8:8. 
© 2013 Harris et al.; licensee BioMed Central Ltd.  
This is an Open Access article distributed under the terms of 
the Creative Commons Attribution License 
(http://creativecommons.org/licenses/by/2.0), which 
permits unrestricted use, distribution, and reproduction in 
any medium, provided the original work is properly cited. 
Implementation
Science
Harris et al. Implementation Science 2013, 8:8
http://www.implementationscience.com/content/8/1/8STUDY PROTOCOL Open AccessPreventive evidence into practice (PEP) study:
implementation of guidelines to prevent primary
vascular disease in general practice protocol for a
cluster randomised controlled trial
Mark F Harris1*, Jane Lloyd1, John Litt2, Mieke van Driel3, Danielle Mazza4, Grant Russell4, Jane Smith5,
Chris Del Mar5, Elizabeth Denney-Wilson6, Sharon Parker1, Yordanka Krastev7, Upali W Jayasinghe1, Richard Taylor8,
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Background: There are significant gaps in the implementation and uptake of evidence-based guideline
recommendations for cardiovascular disease (CVD) and diabetes in Australian general practice. This study protocol
describes the methodology for a cluster randomised trial to evaluate the effectiveness of a model that aims to
improve the implementation of these guidelines in Australian general practice developed by a collaboration
between researchers, non-government organisations, and the profession.
Methods: We hypothesise that the intervention will alter the behaviour of clinicians and patients resulting in
improvements of recording of lifestyle and physiological risk factors (by 20%) and increased adherence to guideline
recommendations for: the management of CVD and diabetes risk factors (by 20%); and lifestyle and physiological
risk factors of patients at risk (by 5%). Thirty-two general practices will be randomised in a 1:1 allocation to receive
either the intervention or continue with usual care, after stratification by state. The intervention will be delivered
through: small group education; audit of patient records to determine preventive care; and practice facilitation visits
adapted to the needs of the practices. Outcome data will be extracted from electronic medical records and patient
questionnaires, and qualitative evaluation from provider and patient interviews.
Discussion: We plan to disseminate study findings widely and directly inform implementation strategies by
governments, professional bodies, and non-government organisations including the partner organisations.
Keywords: Primary care, Family medicine, Guidelines, Preventive care, Cardiovascular diseaseBackground
Cardiovascular disease (CVD) represents a substantial
and increasing portion of healthcare expenditure and
practitioner workload [1]. It is estimated that 9 in 10
adult Australians have at least one risk factor for CVD
[2]. Behavioural risk factors include smoking, nutrition,
alcohol, physical activity, and being overweight or obese.
The physiological risk factors include high blood pres-
sure and dyslipidaemia [3].* Correspondence: m.f.harris@unsw.edu.au
1Centre for Primary Health Care and Equity, University of New South Wales,
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reproduction in any medium, provided the orPrimary care providers are well placed to help reduce
the incidence of CVD. General practitioners provide
clinical services to approximately 88% of Australians
each year and are in an ideal position to screen for risk
factors and provide brief interventions including advice
about behavioural risk factors as well as medications [1].
However, there are numerous barriers to implementa-
tion at the patient, practitioner, practice, and system
levels [4-7].
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the National Vascular Disease Prevention Alliance have
published guidelines that address the major behavioural
and physiological risk factors for vascular disease. These
guidelines synthesise the evidence for preventing CVD
and provide clear messages for primary care providers
on what targets to aim for and what strategies might be
best employed at the patient provider interaction.
A number of these guidelines refer to the 5As frame-
work, which describes how general practice staff can
intervene to prevent CVD [8]. This framework describes
the pathway and informs the role of different providers
and services in preventive care (Figure 1).
The guidelines have been widely disseminated and well
received. However implementation requires more than
dissemination [9], it requires a tailored approach to
generate change in clinicians behaviour [10], and there
exists evidence of gaps between the guideline recom-
mendations and their implementation in Australian
general practice [7,11,12]. Some of the reasons for the
failure to implement prevention guidelines are related to
the complexity of guideline recommendations and pa-
tient, practitioner, and practice barriers [7,13], including
lack of capacity to provide brief interventions or refer
for more intensive education and support [14,15].
Patients’ understanding of prevention is variable: they
lack knowledge about what preventive care is what is
relevant to them, and there is a tendency for patients
with low health literacy and education attainment to be
less likely to ask for, and therefore to receive, preventive
care [16,17]. The culture of individual practices, their
openness to change, and the number and experience of
providers, all influence the ability to implement prevent-
ive guideline recommendations [18].
The Preventive Evidence into Practice (PEP) study is a
partnership between New South Wales, Flinders,
Monash, Bond, and Queensland Universities, the Royal
Australian College of General Practitioners (RACGP),
the National Heart Foundation of Australia (NHFA), and
the BUPA Foundation. The PEP study is a national, clus-
ter randomised control trial of an intervention designed
to support general practices to implement the recom-
mendations of evidence-based clinical managementASSESS
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to change
ADVISE
Motivational 
counselling 
and education 
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Ask/ 
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Figure 1 The 5As conceptual model.guidelines for the prevention of CVD in general practice
among patients aged 40 to 69 years.
This study aims to evaluate the impact of the PEP
intervention on: The behaviour of doctors and nurses in
general practice in assessing and recording risk factors
and providing interventions to address these; and patient
behavioural and physiological risk factors.
We hypothesise that, for patients aged 40 to 69 years,
the PEP intervention measured at the practice level
over 12 months will improve: by 20% recording of be-
havioural and physiological risk factors; by 20% the
adherence to the recommendations of guidelines for
the management of these risk factors; and by 5% the life-
style and physiological risk factors of patients with the
risk factors.Methods
Study design
The study is a cluster randomised controlled trial con-
ducted in general practices in four states. This design
was chosen because the primary intervention will be at
the practice level and outcomes will be measured at the
patient level.
Randomisation
Practices will be randomly assigned to intervention and
late intervention (control) groups after stratification into
blocks by state and practice size—i.e., the number of
general practictioners (GPs) in a practice—using a
computer-generated randomization list. Randomisation
will be conducted centrally, after completion of the base-
line general practice and practice nurse (PN) surveys, by
one of the investigators, a statistician not involved in the
data collection or intervention (UJ). Results of the
randomisation will communicated to the project man-
agement committee prior to the commencement of the
intervention.
Setting
The study is being conducted in general practices in four
primary care organisations (Medicare Locals) in urban
areas during 2012 and 2013. 
ASSIST
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Intervention development
The process for intervention development broadly fol-
lowed the framework for design of complex interven-
tions [19]. In order to inform the development of the
PEP intervention we initially conducted a review of the
literature [20]. This identified effective strategies for
implementation of guidelines, including establishing
small group education sessions with patients, clinician
prompts and decision aids, audit and feedback, and ex-
ternal facilitation [21]. Educational interventions that are
interactive, provided feedback to participants, include an
objective assessment of education needs and involve
small groups are more likely to be effective [22,23].
Small group interventions are most effective because
they combine evidence-based material with peer influ-
ence [24]. Audit and feedback can be effective in provid-
ing more preventive care [25]. The variation of effect
can be explained by the different ways in which audits
are conducted and how feedback is provided. External
facilitation has been shown to be effective in improving
preventive care [26]. Facilitation is usually included as
part of a multifaceted intervention that includes auditing
medical records.
We then conducted a mixed method study involving
eight Sydney based general practices which included
qualitative interviews with eight staff from two divisions
of general practice, one allied health provider, eight GPs,
four PNs, three practice managers and 24 patients. We
also conducted a clinical audit of medical records in the
eight practices for CVD preventive activities (for 2,409
patients aged 40 to 69 years). The findings from this,
and the literature review, were discussed at a workshop
involving the investigators and partners and external
stakeholders including consumers, professional organisa-
tional representatives, and policy makers. The interven-
tion was then piloted in three Sydney general practices
and evaluated through audio recording of facilitation
visits and interviews with practice staff before and after
the intervention. The analysis resulted in changes to the
audit feedback to practices, the program of practice vis-
its, and the resources provided to practices. Following
the pilot a facilitator manual was developed and dis-
cussed among the investigators prior to finalisation.Description of intervention
The intervention is at the practice level. It will be carried
out over a six-month period, and consists of a training
workshop, three practice visits by a facilitator in each
state based in the Medicare Local, and three follow-up
phone calls. The facilitators will be trained together
using the facilitator manual and case examples from the
pilot study.The training workshop for GPs and PNs in each state
on the prevention of CVD will be overseen and pre-
sented by a Chief or Associate Investigator, the Interven-
tion Facilitator and a Division of General Practice/
Medicare Local staff member. GPs and PNs from each
of the intervention practices will attend the workshops.
The format of the workshop will include an introductory
presentation followed by case studies and role plays
using simulated patients. The workshop introduces the
5As for smoking, nutrition, alcohol, physical activity,
overweight, blood pressure, cholesterol, diabetes and ab-
solute cardiovascular risk, and kidney disease. Guidelines
that provide unambiguous advice and require fewer
changes to practice are easier to implement. Thus,
guideline recommendations have been synthesised
across the 5As framework into a quick reference guide
on two sides of an A4 sheet (Figure 2). These will be
used as the basis for case discussion in the workshop.
A clinical audit will be provided to the GPs and PNs at
baseline and 12 months for patients aged 40 to 69 with-
out heart or kidney disease, stroke, or diabetes. This will
focus on body mass index (BMI) and waist circumfer-
ence, BP, lipids, fasting glucose, and absolute cardiovas-
cular risk. This will include analysis of both the
recording of behavioural and physiological risk factors
and the risk factors themselves. Comparative data are
provided from other practices together with a commen-
tary prepared by an investigator in each state asking
questions and suggesting areas for improvement.
The three practice visits will occur at regular intervals
within the six-month intervention period. Each practice
will be asked to identify a prevention coordinator who is
the key contact person for the research at the practice
level (preferably the PN). Each practice visit will be of
approximately 1 to 1.5 hours duration and include the
GP(s), the PN, and possibly the practice manager. The
practice visits will be conducted by the Intervention
Facilitator and are designed to occur at regular intervals
in order to build momentum and facilitate change at the
practice level. They will discuss the provision of prevent-
ive care for each of the behavioural and physiological
risk factors across the 5As (Figure 3).
Practice visit one will occur between one and four
weeks post the training workshop. At this visit, the base-
line audit results will be reviewed and two to three goals
for improvement established. These goals might be to
improve recording of certain risk factors, and intensify
prescribing or advice given or referral to other services.
Resources and local referral links will be provided and
discussed at this initial visit as necessary.
Practice visit two will occur between three and four
weeks after visit number one. The purpose of this visit
will be to reflect on progress towards meeting the goals
for improvement. Any barriers will be discussed and
5As Assess Advise/Agree Assist/ Arrange
Smoking Smoking status  and readiness to change if 
smoker every visit
Advise to quit. Set quit date.
Consider pharmacotherapy
Refer to 
Quitline.
Arrange follow 
up
Nutrition Ask portions of fruit and 
vegetables per 
day every 2 years 
Brief advice to reduce &and 
increase fruit and vegetable 
portions (2+5)
Refer high risk to a 
dietitian or group 
diet program
Arrange follow up
Alcohol Ask about quantity &frequency of alcohol 
intake  every 3-4 years
Advise <2 drinks per day and 
no more than four drinks on 
any one occasion
Arrange 
follow up
Physical 
activity
Ask (every 2 years)  
about minutes of mod 
physical activity per 
day and days per 
week 
Advise  30min of 
moderate activity 
most  days of the 
week(>2.5 hrs  wk) 
Refer high risk to 
exercise professional or 
PA program. Arrange 
follow up
Weight
Measure BMI 
(Wt/H2) and Waist 
circumference 2 
yearly
Individual including 
both physical 
activity and diet.  
Refer high risk to a 
dietitian or group 
diet program. 
Arrange follow up
5-10%  
Wt 
loss
Stop
2 fruit 
5 veg
Low fat
< 2 
Standard 
Drinks
30min 
/day
5As Assess Advise/Agree Assist/Arrange
Absolute 
CVD risk
Assess every 2 years 
from age 45+ years
Tailor lifestyle and 
medication 
management to 
level of risk 
Refer moderate/high risk to 
diet and physical activity 
program or provider.  
Arrange follow up
Diabetes 
risk
Assess using 
AUSDRISK from age 
40+ year s (18 years 
in ATSI) every 3 
years
Risk score 15+ 
reduce weight & 
improve diet and 
physical activity
Refer at risk to a dietitian or 
group diet program
Arrange follow up
Blood 
pressure
Measure every 2 
years
Low–Mod Absolute 
risk Lifestyle 
High risk Lifestyle + 
pharmacotherapy 
Arrange follow up
Lipids Measure every 5 years from 45 
years
Low–Mod: risk  
Lifestyle 
High risk: Lifestyle + 
pharmacotherapy 
Arrange follow up
Renal 
disease
Urinalysis  from age 50 
years every 5 yr
Creatinine/ eGFR
Microalbumin high risk*
Pharmacotherapy 
(ACEi or ARB)
Weight reduction if 
obese.
Refer eGFR<30 
Arrange follow up
<10%  –
low
10-15%   
- mod
>15% -
high 
<140/90
LDL<2
HDL>1
TG<15
*High risk: hypertension, diabetes, obesity, ATSI or family history every 1 year
Reduce 
Wt
5-10% 
Maintain 
GFR
Figure 2 Reference guide: summary of guideline recommendations across the 5As.
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particular focus in this visit will be on ensuring that pre-
ventive care is available for all patients including disad-
vantaged patients who may have low health literacy.
Practice visit three occurs between three and four
weeks after visit number two. The purpose of this visit is
to monitor improvements, workshop ways to overcome
barriers and discuss how improvements might be main-
tained and incorporated as part of routine practice.
The Intervention Facilitator will conduct three follow-
up and troubleshooting phone calls with the prevention
coordinator. Each of the practice visits will beinterspersed by a follow-up or trouble shooting phone
call initiated by the intervention facilitator. Additional
contact may be initiated by the prevention coordinator
as required.
Participants and recruitment
Eight practices have been recruited by a primary care or-
ganisation (Medicare Local) in each of the four states (a
total of 32 practices). Staff members from the Medicare
Locals approached practices that met the eligibility cri-
teria, such as having computerised medical records to
enable an audit of medical records using the Pen Clinical
Clinical audit
Description of 
practice roles and 
organistion
Review of clinical 
audit
Identification of areas 
of improvement and 
barriers
Goals to improve 
preventive care in 
practice
Plan for improvement
Ideas, resources, and 
links  to support 
change 
Monitor  andfollow 
up
Problem solving
Maintenance of 
changes
Figure 3 The intervention.
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http://www.implementationscience.com/content/8/1/8Audit Tool (Pen CAT) [27] and a PN. Of the 47 prac-
tices who expressed interest in the study and who were
subsequently visited, 32 agreed to participate, a response
rate of 68%. Figure 2 shows the selection and randomisa-
tion process.
In each practice, participants include practice staff and
patients. As a minimum, at least one GP, one PN and
one practice manager from each practice is involved in
the study. However, in some of the group practices, two
or more GPs are involved in the research. Of the 32
practices involved in the research, only seven are in solo
practices whereas 15 of the practices employ five or
more GPs and ten of the practices employ between two
and four GPs (Figure 4).
The patients of the practice will be involved in the
study in two ways. Firstly the records of all patients aged
between 40 to 69 years who are active patients of the
GPs who agree to participate in the study, and without
known cardiac disease, stroke, or diabetes will be
extracted in a de-identified audit at baseline and
12 months. In order to be seen as an active patient for
the purpose of this study, patients must have visited
their GP within the practice at least once in the last
12 months. Secondly, a random sample of 160 patients
from each practice who consent and meet the eligibilityStandards of Reporting Trials (
Assessed for e
Allocated to intervention (n=16 practices)
Solo practice (n=3)
2-4 GPs (n=6)
More than 5 GPs (n=7)
Allo
Randomize
Enro
Figure 4 Participant Flow Diagram for the PEP Study consistent with
statement.criteria will be invited to complete the patient survey.
To be eligible to participate in the study patients must
have sufficient English and cognitive ability to under-
stand the patient information letter, consent form, and
written questionnaire.
Data collection procedures
Data will be collected from the practices, the practi-
tioners and the patients for all 32 practices involved in
the study (Figure 5). Data will be collected from prac-
tices by field research staff not involved in the conduct
of the intervention. However, it may not be possible to
fully blind them to allocation because practice staff may
incidentally inform them during their visits.
The practice manager or the principal GP from each
practice will be asked to complete a Practice Assessment
Survey that collects descriptive information about the
practice, including the location of the practice, number,
type, and roles of staff members and information sys-
tems used. This information will assist us in understand-
ing how the practice operates and therefore in
identifying opportunities to facilitate preventive care.
During the analysis phase of the research, the collation
of practice information will enable us to examine
whether any patterns of preventive care improvementsCONSORT) 2010 statement
ligibility (124)
Excluded  (n= 92)
Not meeting inclusion criteria (n=8)
Declined to participate (n=81)
Other reasons (n=3)
Allocated to late intervention (n=16 practices)
Solo practice (n=4)
2-4 GPs (n=4)
More than 5 GPs (n=8)
cation
d (32 practices)
llment
♦
♦
♦
the Consolidated Standards of Reporting Trials (CONSORT) 2010
Step 1
Practice Recruitment
General practices invited
Interested practices sent Invitation Letter + Information 
Sheet + Informed Consent/Revocation of Consent Form
Practices recruited (n = 32)
Step 2
Baseline data collection Part  
1 and Patient recruitment 
Practices complete Assessment Survey
GPs and practice nurses complete GP+Practice Nurse 
Survey
Baseline Clinical Audit conducted
Practices identify eligible patients (n=160). Patients 
sent Invitation Letter + Information Sheet + Informed
Consent /Revocation of Consent Form + Survey
Step 3
Practice Randomisation
Intervention group (n = 16)
Control group (n = 16)
Baseline data collection  
Part 2
Clinical Audit reports prepared
GP, practice nurse and practice manager interviews 
held (only with the staff members from two Intervention 
practices/State)
Step 4
Intervention
Training session for GPs and practice nurses 
Telephone calls to practices
Intervention Practice Visits (n = 3)
Step 5
12-month Follow-up data 
collection
Clinical Audit
GP and practice nurse Survey 
Patient Survey
GP, Practice Nurse and Practice Manager Interviews
Patient Interviews
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
Figure 5 Step by step description of the PEP study.
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work arrangements.
Information will then be collected from the practi-
tioners at baseline and again at 12 months. The GPs and
PNs are asked to complete a survey that asks about their
demographic characteristics and years in practice, and
also how preventive care assessment and management is
provided including frequency of assessment and man-
agement of the behavioural and physiological risk fac-
tors. This survey is based on questions from the
Preventive Medicine Attitudes and Activities Question-
naire (PMAAQ) [28] used by us in previous research [29].
Patient information is also collected at baseline and
again at 12 months to enable us to identify changes in
the level of risk for CVD (Table 1). The medical record
audit is conducted by the field research staff using the
Pen CAT tool [27] The data extracted includes de-
identified information on the recording and level of life-
style and physiological risk factors, and the management
of hypertension, dyslipidemia, diabetes, and CVD risk
assessment. The patient survey is based on the NSW
Health Survey [30] and previous research [31]. The sur-
vey includes questions about practice attendance,
reported assessment and management of behavioural
risk factors—smoking, nutrition, alcohol, physical activ-
ity and weight (SNAPW)—in general practice [7], atten-
dances at other services as a result of referral from thepractice or self-referral, self-reported fruit and vegetable
intake [32], smoking, physical activity [33] and alcohol
intake [34], and readiness for behaviour change (stage of
change) for each SNAPW risk factor [35].
Qualitative study
A purposive sample of eight intervention practices (two
in each state that includes a cross section of various
practice sizes) will be qualitatively studied. This study
will determine what individual and organisational factors
explain the success of the PEP intervention and explore
the role of the intervention facilitator in supporting
practices to make improvements. The qualitative study
is broadly informed by a variety of theories and frame-
works that help us to understand the organizational rou-
tines and patterns of work [37,38], practice systems
[39-41], and the way in which change is enacted and
adapted in practices [42] and a framework for
organization of care activities (Chronic Care Model)
[43]. The study will include qualitative interviews con-
ducted by the field researchers with practice staff
involved in the intervention early and late in the inter-
vention process. Other qualitative data will be collected
from the intervention facilitators, including a diary of
meeting and contacts with the practice, their notes on
the implementation of the intervention, and an interview
towards the end of the intervention period. Analysis will
Table 1 Outcome Variables
Category Measures Time Point
Primary
Recorded risk factors Proportion of eligible patients with the following recorded 0 and 12 months
• In the previous 24 months:-
o Blood pressure (in patients without hypertension)
o Weight (with height for BMI)
o Waist circumference
o Fasting blood glucose
oFasting Lipids
• Ever:-
o Smoking status
o Alcohol intake
Recalled Advice Proportion of eligible patients who were at risk who recalled being offered advice: 0 and 12 months
• Diet (fruit and vegetables, low saturated fat)
• Physical activity
• Weight control
Medication Change in medications over previous 12 months 0 and 12 months
• lipid lowering,
• antihypertensive
Risk factors Self assessed: 0 and 12 months
• Physical activity score*
• Diet score**
• Smoking Status
• Alcohol intake (standard drinks per week)
Measured
• BMI
• waist circumference
• blood pressure
• lipids (TC, LDL-C, HDL-C, TG).
Secondary
GP or nurse preventive care • Self reported assessment 0 and 12 months
• Self reported advice
GP or nurse • attitudes to preventive care in general practice 0 and 12 months
* Physical activity level which combines assessment of duration of vigorous and moderate physical activity (scored 0-8, <4 considered at risk) [36].
** Serves of fruit and vegetables per day.
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previously trialed by Cohen et al. [44]. This will charac-
terise narratives of the intervention at each study site
looking for variation of key components, focus at each
practice, and identifying factors which influence (or are
perceived as influencing) the intervention.Study size
The trial is being conducted in 32 practices. We estimate
that the number of GPs and PNs recruited to the study
will be 80.We estimate that the records of at least 500 patients
will be audited in each practice (i.e., 8,000 total). Assum-
ing a design effect due to clustering of 1.8 based on pre-
vious studies [45], a sample of 188 patients in each
group would have sufficient power (β = 0.8 and α = 0.05)
to detect a 20% difference in the proportion of patients
whose lifestyle and physiological risk factors are
recorded. A sample size of 500 would have sufficient
power to detect an effect size if 0.3 in recorded BMI
(based on ICC = 0.047), LDL-Cholesterol (ICC 0.059),
and systolic blood pressure after adjusting for clustering
(ICC 0.062) [29,46,47].
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to participate in the patient survey per practice or 640
patients in each arm of the trial. Allowing for 10% loss
to follow up at 12 months, this will leave 36 patients per
practice (576 in each group). Assuming a design effect
due to clustering of two based on previous studies, a
sample of 500 patients in each group would have suffi-
cient power (β = 0.8 and α = 0.05) to detect a 15% differ-
ence in the proportion of patients offered education for
diet or physical activity after adjusting for clustering
(ICCs 0.051 and 0.035) and a 10% difference referral
(ICCs 0.026 and 0.011). This sample size would have suf-
ficient power to detect an effect size of 0.3 in serves of
fruit and vegetables consumed (ICC 0.001) and physical
activity scores (ICC 0.018) [33].
Statistical methods
We will examine the change of study variables within
the intervention and control practices before and after
interventions and compare the difference of outcomes
between the two groups after adjusting for baseline dif-
ferences. Primary analyses will be by intention to treat
(patients and practices will be analysed as randomised,
rather than by intervention actually received). We will
analyse patient variables (risk behaviour, health service
use, blood pressure, total cholesterol, HDL, LDL,
General Practice Assessment Survey (GPAS) for within
and between group differences using multilevel regres-
sion techniques adjusted for clustering of patients (level
one) within practices (level two). The pre-randomisation
value of each outcome will be used as lag covariates.
Interactions as well as main effects will be tested. Sec-
ondary analysis will compare patients who were referred
against those who were not, and defined as at risk. For
cases lost to follow up at 12 months, we will conduct
sensitivity analyses of the primary and secondary out-
comes to determine the effect of their inclusion assum-
ing no change in the outcome variables.
Ethics
The study has been approved by the Royal Australian
College of General Practitioners Human Research Ethics
Committee and the Southern Adelaide Clinical Human
Research Ethics Committee. This approval has been
endorsed by the Human Research Ethics Committees at
the University of New South Wales, Monash University,
Bond and Queensland Universities. We obtained full
informed written consent from participants.
Project management
The study is led by a project management committee
that comprises the investigators and the project coordin-
ator, which meets bimonthly. Intervention- and data col-
lection subcommittees meet as required. There are ChiefInvestigators (CIs) from each of the four states partici-
pating in the study who implement the study in each
state together with the Field Research Officers and the
Intervention Facilitators. The Field Research Officers are
responsible for the data collection. Their roles include
conducting the clinical audit and administering surveys
and interviewing practice staff and patients. The Field
Research Officers are based at the local University and
do not interact directly with the intervention facilitators.
The Intervention Facilitators are responsible for working
with practices to facilitate improvements in preventive
activities. Their roles include working with practices to
set appropriate targets and goals, provide resources to
assist the practices in meeting their goals, monitoring
improvements, and identifying how changes and
improvements can be maintained. It is necessary that
the data collection and the facilitation roles are carried
out by different staff members so as not to contaminate
the results. The Intervention Facilitators are based in the
local Division of General Practice or Medicare Local.
Trial status
The trial is registered with the Australian Clinical Trials
Registry ACTRN12612000578808.
The trial is underway with baseline data collection
complete and the intervention commenced.
Discussion
The PEP study aims to evaluate the effectiveness of an
implementation strategy for cardiovascular preventive
care guidelines in Australian general practice. This has
the potential to address a significant evidence to practice
gap. Although there is self-reported use of guidelines by
most GPs, this does not mean that the guideline recom-
mendations are routinely followed [48]. There are sig-
nificant barriers to be overcome, and considerable
variation exists between practices and practitioners in
their readiness to implement evidence based care [49].
Effective practice interventions need to be tailored to
the barriers and local context [50], be multifaceted [10],
and involve the entire primary care team [51]. Thus, the
implementation strategy has been designed to take into
the context of individual practices and their staff with a
flexible approach based on small group education, med-
ical record audit, and practice facilitation. This is a
unique approach in the Australian context and one that
is also being explored overseas [52].
The complexities of applied research have led us to
shift our focus from examining what works in prevent-
ing CVD generally, to focus more specifically on how
primary care practices can be best supported in different
contexts. By working with practices across four states in
Australia, we hope to identify important characteristics
and processes that can help generate and sustain a
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tion of this partnership project is to ensure that the find-
ings emerging from the research are communicated to a
range of government and non-government organisations.
Space has been allocated into the timeframe to enable
potential implementation strategies and operational
changes to be considered as part of the project dissemin-
ation process.
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